The Chicago Consensus on Peritoneal Surface Malignancies: Standards

Chicago Consensus Working Group

doi:10.1245/s10434-020-08325-9

The Chicago Consensus on Peritoneal Surface Malignancies: Standards

Chicago Consensus Working Group

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

The Chicago Consensus Working Group provides the following multidisciplinary recommendations for the care of patients with peritoneal surface malignancies. This article focuses on the standards of a peritoneal surface malignancy center, standards of billing and coding, standards of operative reports for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, standards of cytoreductive surgery training, and standards of intraoperative chemotherapy preparation. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.

Original language	English (US)
Pages (from-to)	1743-1752
Number of pages	10
Journal	Annals of surgical oncology
Volume	27
Issue number	6
DOIs	https://doi.org/10.1245/s10434-020-08325-9
State	Published - Jun 1 2020

Funding

James C. Cusack reports grants from Lumicell Inc. outside the submitted work. Carla Harmath serves on the medical advisory council of Accumen. Hedy Kindler reports personal fees and non-financial support from Inventiva, AstraZeneca, Boehringer Ingelheim, Merck, and Paredox; personal fees from Aldeyra Therapeutics, Bayer, BMS, Erytech, Five Prime Therapeutics, Ipsen Pharmaceuticals, Kyowa, and MedImmune; and funds to support clinical trials at her institution from Aduro, AstraZeneca, Bayer, BMS, Deciphera, GSK, Lilly, Merck, MedImmune, Polaris, Verastem, and Blueprint, all outside the submitted work. Garrett M. Nash reports non-financial support from Intuitive, outside the submitted work. Aytekin Oto reports grants from Philips Healthcare, Guerbet, and Profound Healthcare, and serves as a medical advisory board member for Profound Healthcare, all outside the submitted work. Nita Ahuja reports grant funding from Cepheid and Astex, has served as a consultant to Ethicon, and has licensed methylation biomarkers to Cepheid. Jesus Esquivel reports personal fees from Eight Medical. The remaining authors disclosed no conflicts of interest.

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-020-08325-9

Cite this

@article{ae4dc1f5bb8d43bf968f0f624688eb4a,

title = "The Chicago Consensus on Peritoneal Surface Malignancies: Standards",

abstract = "The Chicago Consensus Working Group provides the following multidisciplinary recommendations for the care of patients with peritoneal surface malignancies. This article focuses on the standards of a peritoneal surface malignancy center, standards of billing and coding, standards of operative reports for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, standards of cytoreductive surgery training, and standards of intraoperative chemotherapy preparation. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.",

author = "{Chicago Consensus Working Group} and Alejandro Plana and Izquierdo, {Francisco J.} and Darryl Schuitevoerder and Abbott, {Daniel E.} and Sherif Abdel-Misih and Ahrendt, {Steven A.} and Mazin Al-kasspooles and Farin Amersi and Arrington, {Amanda K.} and Brian Badgwell and Barone, {Robert M.} and Baumgartner, {Joel M.} and Berri, {Richard N.} and Lana Bijelic and Bowne, {Wilbur B.} and Blazer, {Dan G.} and Brown, {Charles Komen} and Catenacci, {Daniel V.} and Chan, {Carlos H.F.} and Cho, {Clifford S.} and Choudry, {M. Haroon A.} and Clarke, {Callisia N.} and Cusack, {James C.} and Dachman, {Abraham H.} and Deneve, {Jeremiah L.} and Dineen, {Sean P.} and Eng, {Oliver S.} and Fernandez, {Leopoldo J.} and James Fleshman and Gamblin, {T. Clark} and Alexandra Gangi and Georgakis, {Georgios V.} and Gilbert, {Erin W.} and Goodman, {Martin D.} and Anand Govindarajan and Grotz, {Travis E.} and Vadim Gushchin and Nader Hanna and Carla Harmath and John Hart and Andrea Hayes-Jordan and Husain, {Aliya N.} and Kamran Idrees and Chukwuemeka Ihemelandu and Haejin In and Johnston, {Fabian M.} and David Jiang and Kane, {John M.} and Giorgos Karakousis and Merkow, {Ryan P.}",

note = "Publisher Copyright: {\textcopyright} 2020, American Cancer Society and Society of Surgical Oncology.",

year = "2020",

month = jun,

day = "1",

doi = "10.1245/s10434-020-08325-9",

language = "English (US)",

volume = "27",

pages = "1743--1752",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "6",

}

TY - JOUR

T1 - The Chicago Consensus on Peritoneal Surface Malignancies

T2 - Standards

AU - Chicago Consensus Working Group

AU - Plana, Alejandro

AU - Izquierdo, Francisco J.

AU - Schuitevoerder, Darryl

AU - Abbott, Daniel E.

AU - Abdel-Misih, Sherif

AU - Ahrendt, Steven A.

AU - Al-kasspooles, Mazin

AU - Amersi, Farin

AU - Arrington, Amanda K.

AU - Badgwell, Brian

AU - Barone, Robert M.

AU - Baumgartner, Joel M.

AU - Berri, Richard N.

AU - Bijelic, Lana

AU - Bowne, Wilbur B.

AU - Blazer, Dan G.

AU - Brown, Charles Komen

AU - Catenacci, Daniel V.

AU - Chan, Carlos H.F.

AU - Cho, Clifford S.

AU - Choudry, M. Haroon A.

AU - Clarke, Callisia N.

AU - Cusack, James C.

AU - Dachman, Abraham H.

AU - Deneve, Jeremiah L.

AU - Dineen, Sean P.

AU - Eng, Oliver S.

AU - Fernandez, Leopoldo J.

AU - Fleshman, James

AU - Gamblin, T. Clark

AU - Gangi, Alexandra

AU - Georgakis, Georgios V.

AU - Gilbert, Erin W.

AU - Goodman, Martin D.

AU - Govindarajan, Anand

AU - Grotz, Travis E.

AU - Gushchin, Vadim

AU - Hanna, Nader

AU - Harmath, Carla

AU - Hart, John

AU - Hayes-Jordan, Andrea

AU - Husain, Aliya N.

AU - Idrees, Kamran

AU - Ihemelandu, Chukwuemeka

AU - In, Haejin

AU - Johnston, Fabian M.

AU - Jiang, David

AU - Kane, John M.

AU - Karakousis, Giorgos

AU - Merkow, Ryan P.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - The Chicago Consensus Working Group provides the following multidisciplinary recommendations for the care of patients with peritoneal surface malignancies. This article focuses on the standards of a peritoneal surface malignancy center, standards of billing and coding, standards of operative reports for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, standards of cytoreductive surgery training, and standards of intraoperative chemotherapy preparation. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.

AB - The Chicago Consensus Working Group provides the following multidisciplinary recommendations for the care of patients with peritoneal surface malignancies. This article focuses on the standards of a peritoneal surface malignancy center, standards of billing and coding, standards of operative reports for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, standards of cytoreductive surgery training, and standards of intraoperative chemotherapy preparation. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.

UR - http://www.scopus.com/inward/record.url?scp=85083312765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083312765&partnerID=8YFLogxK

U2 - 10.1245/s10434-020-08325-9

DO - 10.1245/s10434-020-08325-9

M3 - Article

C2 - 32285276

AN - SCOPUS:85083312765

SN - 1068-9265

VL - 27

SP - 1743

EP - 1752

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 6

ER -

The Chicago Consensus on Peritoneal Surface Malignancies: Standards

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this